对1例西妥昔单抗所致痤疮样皮疹患者的药学监护  

Pharmaceutical care for a patient with acneiform rash caused by cetuximab

作　　者：杨慧 李亚南[1] 席骏钻 沈锦华[1] YANG Hui;LI Ya’nan;XI Junzuan;SHEN Jinhua(Department of Pharmacy,the People’s Hospital of Rugao,Jiangsu Nantong 226500,China)

机构地区：[1]江苏省如皋市人民医院药剂科,江苏南通226500

出　　处：《上海医药》2020年第13期60-62,79,共4页Shanghai Medical & Pharmaceutical Journal

摘　　要：目的 :探索临床药师对使用抗肿瘤靶向药物治疗患者实施药学监护的方法和意义。方法 :临床药师参与1例直肠癌患者使用西妥昔单抗联合化疗的治疗过程,探究导致患者出现痤疮样皮疹的可能原因,提出治疗方案并监护用药治疗全过程。结果 :通过有效的干预和全面的药学监护,患者皮疹得到有效控制。结论 :临床药师对肿瘤患者实施药学监护可有效减轻抗肿瘤靶向药物治疗的不良反应,提高临床抗肿瘤治疗水平,保障肿瘤患者的用药安全。Objective:To investigate the methods and significance of clinical pharmacists in the implementation of pharmaceutical care for a patient treated with anti-tumor targeted drugs.Methods:Clinical pharmacists participated in the whole treatment process of cetuximab combined with chemotherapy in the patient with rectal cancer,explored the possible causes of acneiform rash,proposed a therapeutic regimen and monitored the whole process of medication.Results:The acneiform rash of the patient was effectively controlled by effective intervention and comprehensive pharmaceutical care.Conclusion:The adverse reactions caused by anti-tumor targeted drug can be effectively reduced,the clinical anti-tumor treatment level can be improved and the safety of cancer patients can be ensured by clinical pharmacists in the implementation of pharmaceutical care.

关 键 词：西妥昔单抗 痤疮样皮疹 临床药师 药学监护 

分 类 号：R979.19[医药卫生—药品]